- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/22 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 207/22
Total number of patents in this class: 126
10-year publication summary
12
|
7
|
9
|
7
|
10
|
6
|
11
|
10
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
ObsEva S.A. | 62 |
12 |
FMC Corporation | 850 |
8 |
Allergan, Inc. | 2431 |
6 |
Bayer Cropscience AG | 2136 |
6 |
KYORIN Pharmaceutical Co., Ltd. | 173 |
6 |
Abbvie Inc. | 1785 |
4 |
Glaxo Group Limited | 4250 |
3 |
Novartis AG | 11254 |
3 |
Bristol-myers Squibb Company | 4861 |
3 |
Takeda Pharmaceutical Company Limited | 2945 |
3 |
Merck Patent GmbH | 5856 |
2 |
Centre National de La Recherche Scientifique | 10140 |
2 |
Aix-Marseille Universite' | 37 |
2 |
Cancer Research Technology Limited | 524 |
2 |
Galderma Research & Development | 416 |
2 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3359 |
2 |
Institut Jean Paoli & Irene Calmettes | 127 |
2 |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. | 67 |
2 |
Calico Life Sciences LLC | 85 |
2 |
Canwell Biotech Limited | 17 |
2 |
Other owners | 52 |